Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
REGN

Regeneron Pharmaceuticals

Dow Jones

Dow Jones Now Sliding After Walt Disney Announces 28,000 COVID-19 Layoffs

September 30, 2020 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones now is on the decline due to concerns about a second wave of COVID-19.

There is also plenty of economic uncertainty ahead of the 2020 election.

Shares of Walt Disney Co.

(NYSE: DIS) lead the selloff (down 2%) since the company announced massive layoffs.

Read for everything moving the Dow today.

Read more...

dow jones

Dow Jones Now Slips Despite COVID-19 Vaccine Plans

July 7, 2020 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones now is taking a dip despite news that the U.S. government pumped large amounts of money into a program designed to accelerate the production of a COVID-19 vaccine.

Still, tech stocks were trading at new highs this morning, thanks to a rally in Amazon.com (NASDAQ: AMZN).

Read more...

Stocks

Check Out All the Stocks I'm Buying and Shorting This Week

August 4, 2019 by Chris Johnson

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

So, here we are: The first Fed rate cut in 10 years is in the history books, and the markets have completely changed… right?

Nope. The markets instead took everyone for a roller coaster ride down – selling the news.

But there are still a TON of opportunities out there worth your hard-earned capital, and I'm going to show you the best moves to make when the markets open tomorrow.

We just have to re-focus our attention on the earnings calendar - it's the key to making money this week...

Biotechnology

Get Your Hands on the World's First $1 Billion Cannabis Drug

April 25, 2018 by Michael A. Robinson

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

When it comes to biotech, Wall Street tends to overreact. Though there's no reason for it to be there, biotech is in the dog house, and investors have been conditioned to punish the sector and its stocks whenever the opportunity presents itself.

You see, there are three main reasons biotech is down: Wall Street is worried about high and rising drug prices, the impact of a possible trade war on foreign sales, and expiring patents for some older medications.

Over the last several years, for example, I've read a number of Wall Street reports about the so-called "biotech patent cliff." Simply stated, a drug falls off that "cliff" when its patent runs out and it starts facing competition from generics.

And a number of successful drugs out there are rapidly approaching their patent cliffs.

That sounds bad.

But there are good things happening in biotech, as well. In fact, what you don't hear much about is that the industry is about to bust out.

For example, I was thrilled to see a recent report from Clarivant Analytics, a research firm that works closely with industry leaders and top universities, which says a total of 12 compounds being released in 2018 could become blockbusters.

So I went through the data and found one ultimate biotech blockbuster that I think could lead the pack.

Let's take a look...

Dow Jones

Why the Dow Jones Today Is Flat After Last Night's Elections

November 8, 2017 by Garrett Baldwin

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones today is flat in pre-markets hours after Democrats were swept to victory in Virginia and New Jersey during statewide elections last night.

Dow Jones futures are down nine points as traders are now uncertain over what the elections will mean for Congress, especially as the House gears up for their election in 2018.

Here's a look at today's most important market events and stocks, plus a look at today's economic calendar...

Dow Jones

Dow Jones News Today: Oil Prices Fall to 10-Month Low as OPEC Mulls an Increase in Production Cuts

June 21, 2017 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

In Dow Jones news today, stock prices fell as crude oil prices continue to slide.

Gold prices climbed on the day, but silver prices were down.

But that's not all you need to know - here are all the important stock market stories to look over for June 21...

Stocks

If You Own Just One Pharma Stock, Make It This

April 26, 2017 by Michael A. Robinson

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

As I've said before, buying a drugmaker with true billion-dollar "blockbuster" potential is like grabbing a license to print money.

Of course, it's always at least possible to grab these shares on their way up, but that's a little like fixing the barn door after the horses have bolted.

For the biggest possible pharma profits, investors have to look ahead into the firm's "pipeline," its arsenal of yet-to-be-released drugs that's critical to keeping a drug company competitive in the long term.

Today, I've got the perfect "Buy" recommendation for a company that's doing just that...

biotechnology

These Numbers Prove Big Pharma Is Scared of Trump

February 27, 2017 by Casey Wilson

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Big pharma execs are hoping to avoid President Trump's wrath by drastically reducing the amount of price hikes in 2017.

Producers raised the list prices of 25% fewer drugs than this time last year.

However, this pause on price increases won't last long...

Dow Jones

Dow Jones Industrial Average Slides After October Jobs Report

November 4, 2016 by Garrett Baldwin

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The Dow Jones Industrial Average today is down after the Labor Department reported the U.S. added 165,000 jobs in October.

That missed expectations of 175,000 new jobs.

But that's not the only reason why the Dow is down today- here's all the important stock market information to get you ready for Nov. 4...

Latest News

September 14, 2023 • By Chris Johnson

Tulips Are Telling Me How To Trade the Next 300% rally in AI

September 14, 2023 • By Garrett Baldwin

This Is My Biggest Economic Fear

September 14, 2023 • By Shah Gilani

earnings
What You Should Do About AI's Latest IPO Right Now
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information